These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12927569)

  • 41. Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative?
    Merlano M
    Oncologist; 2006 Feb; 11(2):146-51. PubMed ID: 16476835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A systematic overview of radiation therapy effects in head and neck cancer.
    Zackrisson B; Mercke C; Strander H; Wennerberg J; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):443-61. PubMed ID: 14596506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M; Olszewska E; Maksimowicz T
    Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
    Natale D; Orlando D
    Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
    [No Abstract]   [Full Text] [Related]  

  • 45. Adjuvant therapy in patients with resected poor-risk head and neck cancer.
    Bernier J; Vermorken JB; Koch WM
    J Clin Oncol; 2006 Jun; 24(17):2629-35. PubMed ID: 16763276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is high-dose intensity intraarterial cisplatin chemoradiotherapy for head and neck carcinoma feasible?
    Robbins KT
    Cancer; 2005 Feb; 103(3):447-50. PubMed ID: 15633205
    [No Abstract]   [Full Text] [Related]  

  • 47. Combined-modality therapy for locoregionally advanced head and neck cancer.
    Cmelak AJ; Murphy BA; Day T
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):83-91. PubMed ID: 10550831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
    Overgaard J; Hoff CM; Hansen HS; Specht L; Overgaard M; Lassen P; Andersen E; Johansen J; Andersen LJ; Evensen JF; Alsner J; Grau C
    Radiother Oncol; 2018 Apr; 127(1):12-19. PubMed ID: 29523409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy.
    Marcu LG
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):116-23. PubMed ID: 19267726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of 'in-field' skin toxicity in head and neck cancer patients treated with combined cetuximab and radiotherapy.
    Cante D; La Porta MR; Franco P; Sciacero P; Girelli GF; Marra A; Numico G; Denaro N; Russi EG; Ricardi U
    Oncology; 2013; 85(5):257-61. PubMed ID: 24192693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy in head and neck cancer.
    Hamasaki VK; Vokes EE
    Curr Opin Oncol; 1992 Jun; 4(3):504-11. PubMed ID: 1498159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging role of EGFR-targeted therapies and radiation in head and neck cancer.
    Song J; Chen C; Raben D
    Oncology (Williston Park); 2004 Dec; 18(14):1757-67; discussion 1767, 1771-2, 1777. PubMed ID: 15700625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in radiotherapy for head and neck cancer.
    Mendenhall WM; Parsons JT; Buatti JM; Stringer SP; Million RR; Cassisi NJ
    Semin Surg Oncol; 1995; 11(3):256-64. PubMed ID: 7638513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined treatment techniques in head and neck cancer: radiation therapy, chemotherapy and hyperthermia.
    Brady LW
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):68-74. PubMed ID: 619215
    [No Abstract]   [Full Text] [Related]  

  • 55. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
    Forastiere AA
    J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
    [No Abstract]   [Full Text] [Related]  

  • 56. Paclitaxel in head and neck and other cancers: future prospects.
    Aisner J; Cortés-Funes H
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-113-S2-115. PubMed ID: 9045328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.
    Bucci MK; Rosenthal DI; Hershock D; Metz J; Devine P; Kligerman MM; Machtay M
    Am J Clin Oncol; 2004 Dec; 27(6):595-602. PubMed ID: 15577438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Docetaxel: a new weapon in the treatment of head and neck tumors].
    Melano M
    Tumori; 2001; 87(6):A9-10. PubMed ID: 11995709
    [No Abstract]   [Full Text] [Related]  

  • 59. Intravenous delivery of 5'-iododeoxyuridine during hyperfractionated radiotherapy for locally advanced head and neck cancers: results of a pilot study.
    Epstein AH; Lebovics RS; Van Waes C; Smith J; Okunieff P; Cook JA
    Laryngoscope; 1998 Jul; 108(7):1090-4. PubMed ID: 9665262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update.
    Bernier J
    Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.